Ultrasound attenuation coefficient estimation using aberration compensation and reference phantoms

Disclosed is a method for estimating ultrasound attenuation coefficient by use of aberration compensation and the reference phantom method. Measurements on a human sample at a single transmit frequency and on multiple reference phantoms at a plurality of transmit frequencies are performed respectively. The center frequencies of the echo signals at the depth of the top edge of the region of interest are calculated. A specific reference phantom at a specific transmit frequency is selected by the echo signals whose center frequencies are closest to the center frequencies of the echo signals from the human sample at the aforementioned depth to compensate for the aberration. Then the spectra of the echo signals from the selected reference phantom at the selected transmit frequency and the spectra from the echo signals from the human sample are used to estimate the attenuation coefficient of the human sample by following the reference phantom method.

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a continuation application of International Application No. PCT/CN2024/074594, filed on Jan. 30, 2024, which claims priority to Chinese Patent No. 202410115721.0, filed on Jan. 29, 2024. All of the aforementioned applications are incorporated herein by reference in their entireties.

TECHNICAL FIELD

The application relates to the technical field of quantitative ultrasound, in particular to a method for estimating ultrasound attenuation coefficient using aberration compensation and reference phantom method.

BACKGROUND

In clinical diagnosis of fatty liver, ultrasound attenuation coefficients of liver tissue are generally estimated to determine whether liver tissue lesions occur and what is the extent of lesions. The current method of estimating ultrasound attenuation coefficient is to use a calibrated reference phantom, specifically to measure the power spectra of the echo signals from a human sample and a reference phantom with calibrated attenuation coefficient respectively under the same transmitting and receiving conditions, thereby the ratio of power spectra of the human sample and the reference phantom is a function of depth and the differences of the attenuation coefficients between human sample and the reference phantom. The attenuation coefficient of the human sample is specifically calculated through the following formula:

α s ( f ) = - d ⁡ ( ln ⁡ ( S s ( f , z ) S P ( f , z ) ) ) 4 ⁢ dz + α P ( f ) ,
wherein αs(f) is the attenuation coefficient of the sample, Ss(f, z) is the power spectra of the echo signals from the human sample measured at a certain transmit frequency, and SP(f, z) is the power spectra of the echo signals from the reference phantom measured at a certain transmit frequency. When the transmit frequency is fixed, the ratio of Ss(f, z) and SP (f, z) is a function of the measured depth z; and

d ⁡ ( ln ⁡ ( S s ( f , z ) S i ( f , z ) ) ) 4 ⁢ dz
is the slope or differential value of the logarithm of the power spectra ratio versus the depth in the measured area. When estimating ultrasound attenuation coefficient by the reference phantom method aforementioned, it is assumed that the acoustic paths of the reference phantom and the human body are the same, whereas in human body, ultrasound wave passes through transition zones with different sound velocities and attenuation coefficients such as skin, bones, blood vessels and fat before reaching the target region. This is different from the assumption that the whole velocities and attenuation coefficients are uniform as in the reference phantom. Due to the deviations and differences in the respective acoustic paths between the human body and the reference phantom, the ultrasound attenuation coefficient of the human sample estimated by the conventional reference phantom method has large variation and biases.

SUMMARY

The application aims to provide a method for estimating ultrasound attenuation coefficient by using aberration compensation and reference phantoms, wherein the method can effectively compensate deviations caused by different acoustic paths between the human body and the reference phantoms, thus improve the accuracy of ultrasound attenuation coefficient estimation.

In order to achieve the aforementioned goal, the present application utilizes the following technical solution to estimate ultrasound attenuation coefficient using aberration compensation and reference phantoms: the human sample and N reference phantoms with different attenuation coefficients α1, α2, α3, . . . αN are measured and the center frequencies of the echo signals at the depth d of the human sample and the reference phantoms are calculated respectively, wherein d is the depth at the top edge of the measured region in the human body. For measurements performed on the human body and calculation of the center frequencies of the echo signals at the depth d, the echo signals are acquired and center frequencies are calculated after the transmission of a single frequency f0; whereas for measurements on the N reference phantoms and calculation of the center frequencies of the echo signals at the depth d, the echo signals are acquired and center frequencies are calculated after the transmission of a plurality of m frequencies f1, f2, f3 . . . fm. From the calculated center frequencies at the depth d of the N×m acquired echo signals, a specific reference phantom αi at a transmit frequency fj is selected for echo signals whose center frequencies are closest to the center frequencies of the echo signals from the human sample at the depth d. Finally, the attenuation coefficient of the human sample to be estimated is calculated according to the formula

α s ( f ) = - d ⁡ ( ln ⁡ ( S s ( f , z ) S i ( f , z ) ) ) 4 ⁢ dz + α i ( f ) ,
wherein αs(f) is the attenuation coefficient of the human sample, Ss(f, z) is the power spectra of the echo signals of the human sample at the transmit frequency f0, Si(f, z) is the power spectra of the echo signals of the reference phantom at the selected transmit frequency fj,

d ⁡ ( ln ⁡ ( S s ( f , z ) S i ( f , z ) ) ) 4 ⁢ dz
is the slope or differential value of the logarithm of the power spectra ratio versus the depth in the measured area, and αi(f) is the attenuation coefficient of the selected reference phantom.

Specifically, when performing measurements on the human sample and N reference phantoms with different attenuation coefficients α1, α2, α3, . . . αN, and calculating the center frequencies of the echo signals at the depth d of the human sample and the reference phantoms respectively, the echo signals of the reference phantoms with N attenuation coefficients at m different transmit frequencies can be acquired and saved on a hard disk beforehand; The center frequencies of the echo signals at the depth d from each reference phantom at m different transmit frequencies can be calculated from the already saved data whenever needed to reduce the data acquisition time during actual measurements on the human body.

Specifically, when calculating the center frequencies of the echo signals of the human sample and the reference phantoms respectively at the depth d, the centroid method is employed by using the following formula specifically

f c = ∫ 0 ∞ f ⁢ ❘ "\[LeftBracketingBar]" X ⁡ ( f ) ❘ "\[RightBracketingBar]" ⁢ df ∫ 0 ∞ ❘ "\[LeftBracketingBar]" X ⁡ ( f ) ❘ "\[RightBracketingBar]" ⁢ df ,
where fc is the center frequency, f is the frequency of the echo signals, and X(f) is the spectra of the echo signals at the depth d.

Specifically, when calculating the attenuation coefficient of the human sample, noise reduction on the power spectra Ss(f, z) of the echo signals of the human sample at the transmit frequency f0, and on the power spectra Si(f, z) of the echo signals measured from the reference phantom at the transmit frequency fj is performed, and then the aforementioned formula is used to calculate the attenuation coefficient.

The beneficial effects of this method are: measurements on a human sample with a single transmit frequency and on the reference phantoms with a plurality of transmit frequencies are performed respectively, the center frequencies of the echo signals at the depth at the top edge of the region of interest is calculated, and a specific reference phantom at a specific transmit frequency is selected for the echo signals whose center frequencies are closest to the center frequencies of the echo signals from the human sample and the corresponding transmit frequency, and finally, the spectra of the echo signals from the selected reference phantom together with its corresponding transmit frequency and the spectra of the echo signals from the human sample are used to estimate the attenuation coefficient of the human sample by following the reference phantom method, thereby aberration compensation of signals caused by different acoustic paths between the human sample and reference phantoms is achieved. Consequently, this method effectively improves the accuracy of estimating ultrasound attenuation coefficient of the human sample.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 illustrates a schematic diagram of the acoustic paths of a reference phantom and a human sample in an embodiment and during measurement.

DETAILED DESCRIPTION OF THE EMBODIMENTS

Embodiment 1, referring to FIG. 1, is a method for estimating ultrasound attenuation coefficient using aberration compensation and the reference phantom method comprising the following steps: measurements on a human sample and on a reference phantom with N attenuation coefficients α1, α2, α3, . . . αN are performed and the central frequencies of the echo signals of the human sample and the reference phantoms at the depth d are calculated respectively, wherein d is the depth at the top edge of the region of interest of the human sample.

When performing measurement on a human sample and calculating the center frequencies of the echo signals at the depth d, the echo signals are acquired and calculated after the transmission of a single frequency f0; When performing measurements on the N reference phantoms and calculating the center frequencies of the echo signals at the depth d, the echo signals are acquired and calculated after the transmission of a plurality of m frequencies f1, f2, f3 . . . fm; a specific reference phantom αi at a transmit frequency fj is selected for the echo signals whose center frequencies are closest to the center frequencies of the echo signals of the human sample at the depth d from the multiple N×m echoes at the depth d obtained from the N reference phantoms at a plurality of m transmit frequencies.

Finally, the attenuation coefficient of the human sample is calculated according to the formula

α s ( f ) = - d ⁡ ( ln ⁡ ( S s ( f , z ) S i ( f , z ) ) ) 4 ⁢ dz + α i ( f ) ,
wherein αs(f) is the attenuation coefficient of the human sample, Ss(f, z) is the power spectra of the echo signals of the human sample at the transmit frequency f0, Si(f, z) is the power spectra of the echo signals of the reference phantom at the selected transmit frequency fj,

d ⁡ ( ln ⁡ ( S s ( f , z ) S i ( f , z ) ) ) 4 ⁢ dz
is the slope or differential value of the logarithm of the power spectra ratio versus the depth in the measured area, and αi(f) is the attenuation coefficient of the selected reference phantom.

It should be noted that the power spectra Ss(f, z) and Si(f, z) are functions of transmit frequency f and the detection depth z. When the transmit frequency is fixed, the power spectrum is a function of the detection depth z. In this embodiment, by selecting a reference phantom with a transmit frequency from the echo signals whose center frequencies are closest to the center frequencies of the echo signals from the human sample at the depth d, aberration of the echo signals caused by different acoustic paths between the human sample and reference phantoms is compensated. This effectively improves the accuracy of estimating ultrasound attenuation coefficient of the human sample.

In the estimation method of this embodiment, by using a plurality of m transmit frequencies to measure and calculate the center frequencies of the echo signals of the N reference phantoms with different attenuation coefficients, a reference phantom with a specific transmit frequency that will produce signals whose center frequencies are closest to the center frequencies of the echo signals of the human sample at the depth d can be accurately selected, thereby the efficiency of estimating ultrasound attenuation coefficient of the human sample is increased.

Specifically, when performing measurements on the human sample and the N reference phantoms with different attenuation coefficients α1, α2, α3, . . . αN, and calculating the center frequencies of echo signals at the depth d of the human sample and the reference phantoms respectively, the reference phantoms with N attenuation coefficients at m different transmit frequencies are used, and echo signals for each reference phantom at m different transmit frequencies can be saved in a hard disk beforehand. During actual measurement on the human body and calculation of the center frequencies of the echo signals at the depth d, the center frequencies of echo signals at the depth d of each reference phantom at m different transmit frequencies can be calculated from the already saved echo signals whenever needed. By performing measurements on the N reference phantoms at a plurality of m transmit frequencies and saving echo data in a hard disk beforehand, the stored echo data can be retrieved at any time needed, thereby data acquisition time is reduced, and detection efficiency is improved.

Specifically, when calculating the aforementioned center frequencies of the echo signals of the human sample and the reference phantoms at the depth d, the centroid method is used for calculation by using the following formula specifically

f c = ∫ 0 ∞ f ⁢ ❘ "\[LeftBracketingBar]" X ⁡ ( f ) ❘ "\[RightBracketingBar]" ⁢ df ∫ 0 ∞ ❘ "\[LeftBracketingBar]" X ⁡ ( f ) ❘ "\[RightBracketingBar]" ⁢ df ,
where fc is the center frequency, f is the frequency of the echo signals, and X(f) is the spectra of the echo signals at the depth d. In addition to the centroid method, any method conventionally used in medical ultrasound can also be used for calculating the center frequencies of the echo signals.

Specifically in this embodiment, noise reduction is performed on the power spectra Ss(f, z) of the echo signals of the human sample at the transmit frequency f0, and on the power spectra Si(f, z) of the echo signals measured from the reference phantom at the transmit frequency fj, and then the aforementioned formula to calculate the attenuation coefficient is used. By performing noise reduction on the power spectra of the echo signals, the accuracy of estimating ultrasound attenuation coefficient of the human sample can be further improved; specifically, noise reduction on the power spectra can be performed by filtering, or other noise reduction methods conventionally used.

Certainly, the embodiments above are preferred for the present application only, but the scope of the use of the present application is not intended to be restricted. Therefore, any equivalent changes based on the principles of the present application should be included in the protection scope of the present application.

Claims

1. A method for estimating ultrasound attenuation coefficient using aberration compensation and reference phantom method, comprising the following steps: α s ( f ) = - d ⁡ ( ln ⁡ ( S s ( f, z ) S i ( f, z ) ) ) 4 ⁢ dz + α i ( f ), wherein αs(f) is the attenuation coefficient of the human sample to be estimated, Ss(f, z) is the power spectra of the echo signals of the human sample at the transmit frequency f0, Si(f, z) is the power spectra of the echo signals of the reference phantom at the selected transmit frequency fj, d ⁡ ( ln ⁡ ( S s ( f, z ) S i ( f, z ) ) ) 4 ⁢ dz is the slope or differential value of the logarithm of the power spectra ratio versus the depth in the region of interest, and αi(f) is the attenuation coefficient of the selected reference phantom; f c = ∫ 0 ∞ f ⁢ ❘ "\[LeftBracketingBar]" X ⁡ ( f ) ❘ "\[RightBracketingBar]" ⁢ df ∫ 0 ∞ ❘ "\[LeftBracketingBar]" X ⁡ ( f ) ❘ "\[RightBracketingBar]" ⁢ df, where fc is the center frequency to be estimated, f is the frequency of the echo signals, and X(f) is the spectra of the echo signals at the depth d;

(a) acquiring ultrasound data on a human sample and calculating the central frequencies of echo signals at the depth d after the transmission of a single frequency f0, wherein d is the depth at the top edge of the region of interest;
(b) acquiring ultrasound data on N reference phantoms with N attenuation coefficients α1, α2, α3,... αN after the transmission of a plurality of m frequencies f1, f2, f3... fm on each phantom, and with almost the same settings as in the human study except for the transmit frequencies, and calculating the center frequencies of the echo signals at the depth d;
(c) selecting a specific reference phantom αi with a specific transmit frequency fj so that the center frequencies of its echo signals are closest to the center frequencies of the echo signals from the human sample at the depth d among the central frequencies of the echo signals at the depth d calculated from the N reference phantoms at a plurality of different transmit frequencies;
(d) calculating the attenuation coefficient of the human sample according to the reference phantom method, according to the formula
wherein, when calculating the center frequencies of the echo signals of the human sample and of the reference phantoms at the depth d, using the centroid method by the following formula specifically
wherein before calculation of the central frequencies and the power spectra of the acquired ultrasound data, performing noise reduction on the power spectra of the echo signals of the human sample and on the power spectra of the echo signals from each reference phantom.

2. The method for estimating ultrasound attenuation coefficient using aberration compensation and the reference phantom method according to claim 1, wherein when acquiring ultrasound data on a human sample and N reference phantoms with N attenuation coefficients α1, α2, α3,... αN and calculating the center frequencies of the echo signals of the human sample and the N reference phantoms at the depth d, acquiring the echo signals for each reference phantom at each transmit frequencies and saving ultrasound data on a hard disk before any measurement on the human sample; and calculating the center frequencies and power spectra of the echo signals at the depth d of each reference phantom at each transmit frequency from the already saved echo signals whenever needed.

Referenced Cited
U.S. Patent Documents
11464463 October 11, 2022 Sun
11986269 May 21, 2024 Wang
20040054281 March 18, 2004 Adam
20130199299 August 8, 2013 Wang
20130289381 October 31, 2013 Oraevsky
20130301380 November 14, 2013 Oraevsky
20130338498 December 19, 2013 Emelianov
20200225347 July 16, 2020 Parker
20210018620 January 21, 2021 Oraevsky
20220054001 February 24, 2022 Zhu
20220212036 July 7, 2022 Naqa
20240237965 July 18, 2024 Xu
20250116852 April 10, 2025 Cheng
20250241626 July 31, 2025 Fan
20260102143 April 16, 2026 Besson
Patent History
Patent number: 12733913
Type: Grant
Filed: Dec 23, 2024
Date of Patent: Sep 15, 2026
Patent Publication Number: 20250241626
Assignee: Shantou Institute of Ultrasonic Instruments Co., Ltd. (Shantou)
Inventors: Liexiang Fan (Shantou), Bin Huang (Shantou), Bin Li (Shantou), Yu Wang (Shantou), Haomiao Qiu (Shantou), Yuqiang Kang (Shantou)
Primary Examiner: Sanjay Cattungal
Application Number: 19/000,571
Classifications
Current U.S. Class: Ultrasonic (600/437)
International Classification: A61B 8/00 (20060101); G01S 7/52 (20060101);